Oregon Recalls THC Vape Pods Containing Unapproved Additives

Aug.24.2022
Oregon Recalls THC Vape Pods Containing Unapproved Additives
18,000 THC e-cigarette pods recalled in Oregon due to unauthorized non-cannabis additives, potentially causing respiratory issues.

During an investigation conducted by the Oregon Liquor Control Commission (OLCC) this month, it was found that over 18,000 THC (tetrahydrocannabinol) electronic cigarette pods sold in Oregon between November 2021 and July 2022 contained unapproved non-cannabis additives, which could potentially pose health issues for the respiratory system.


Here is what the recall for the electronic cigarettes shopping cart label looks like:


The marijuana regulatory agency in the state of Oregon has issued a recall for 18,000 electronic THC vape pods manufactured by YHN. The recall notice is printed on the back of the packaging (as shown in the photo from OLCC). The OLCC has initiated the recall of these pods, which were manufactured by YHN and sold in two stores located in the eastern Oregon town of Ontario.


Weedology and The Bud House are two pharmacies in Ontario that sell electronic cigarette pods. They have voluntarily pulled the recalled YHN products from their shelves. So far, the OLCC has not received any reports from consumers who have experienced negative health effects from using these YHN products.


We encourage consumers who have purchased unapproved products to return them to OLCC-licensed retailers or dispose of them. Individuals who have health concerns regarding recalled e-cigarette products should contact their healthcare provider.


The main culprit: Soybean oil.


As part of their ongoing independent investigation, officials from the OLCC tested a range of products from the YHN brand and found that some of their flavoring cartridges for inhalable cannabis may contain soybean oil, which contains triglycerides of glycerol and is prohibited for use in e-cigarette products in Oregon.


Soybean oil is considered a generally recognized as safe (GRAS) food additive by the U.S. Food and Drug Administration. However, this classification is based on ingestion rather than inhalation. When soybean oil is heated into vapor and inhaled, the triglycerides in it may cause various long and short-term health problems, including lipoid pneumonia, a rare lung disease that can cause lung inflammation and breathing difficulties.


Risk: Lipoid Pneumonia


According to data from the National Institutes of Health in the United States, the incidence of lipoid pneumonia is increasing with the rise of nicotine and tetrahydrocannabinol (THC) electronic cigarettes.


According to the National Institutes of Health, an electronic cigarette is defined as a device that uses heat to produce aerosol inhaled by the user from a liquid containing various chemicals, including but not limited to nicotine, artificial flavors, or marijuana. Their guidelines were last updated as of June 2022. A series of cases completed in North Carolina observed five previously healthy individuals who had no underlying conditions, experienced acute respiratory failure requiring hospitalization, and were found to frequently expose themselves to vaporized aerosol in July and August 2019.


In 2019, a vaping-related lung illness known as EVALI resulted in 60 deaths and over 2,800 hospitalizations. This illness was caused by the use of illegal THC vape pods containing vitamin E oil. While this oil has FDA approval for use in a variety of products, it is not suitable for inhalation via vaporization. In response to the EVALI outbreak, Oregon and other legal cannabis states have implemented strict regulations prohibiting certain additives such as vitamin E oil, squalene, and propylene glycol in cannabis vape pods.


Health risks associated with inhaling soybean oil have been observed in both food seasoning and production factories. In 2002, a microwave popcorn factory experienced a mysterious outbreak of bronchiolitis obliterans. Officials investigating the incident at the Centers for Disease Control and Prevention found that workers in the factory had lung problems caused by inhaling aerosolized byproducts of heated soybean oil.


Further punishment will depend on the intent of the production.


In the OLCC investigation into YHN's vape pod, flavors such as "Fruit Blend" and "Green Crack" were tested. Independent testing revealed the presence of ingredients that match those found in soybean oil, a substance banned for use in e-cigarettes in Oregon. It was also discovered that YHN's labeling only partially complied with Oregon's regulations for inhalable cannabinoid products.


The ingredient list of the YHN e-cigarette products that were recalled did indeed include artificial flavorings, and the products were correctly classified according to OLCC rules. However, YHN did not follow OLCC requirements to further break down the ingredients in their artificial flavorings to disclose the presence of soybean oil.


YHN may face a fine of $4,950 or have their marijuana license revoked. These are two very different outcomes, and the punishment may depend on whether OLCC determines that the prohibited additives were intentionally added or due to negligent oversight.


Announcement:


This article has been compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The article's translation is only intended for communication and research within the industry.


Due to limitations in the translator's proficiency, the compiled article may not express the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the position and statements of the Chinese government in relation to any issues pertaining to domestic affairs, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
South Korean tobacco company KT&G launched the limited-edition lil HYBRID 3.0 Misty Rosé Edition II on September 30, 2026, following the original Misty Rosé Edition introduced in November 2025. The new release comes in two pink finishes, Bloom Rosé and Viva Rosé, each priced at 88,000 won. Both versions initially went on sale through the lil Store online shop and lil MINIMALIUM flagship stores. From October 7, Bloom Rosé became available at approximately 1,500 lil Station retail outlets nationwide. The release retains the existing lil HYBRID 3.0 hybrid heated tobacco platform, with changes focused on exterior design and distribution.
product
Oct.10
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22